JAG1 and lung adenocarcinoma: Our study revealed that angiogenic ability can stratify lung adenocarcinoma patients, and the population with higher JAG1 expression characterized by poor prognosis, low degree of T lymphocyte infiltration, high TGF-β response, and active metastasis-related EMT pathway.